Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Galactooligosaccharides (GOS) are prebiotic fibers that have been scientifically validated for their beneficial effects on the small intestine, particularly in terms of supporting gut health and modulating the gut microbiota. Multiple clinical studies have demonstrated that GOS selectively stimulate the growth of beneficial bacteria such as Bifidobacterium and Lactobacillus species in the small intestine and colon. This shift in the microbial community is associated with improved barrier function, enhanced immune response, and reduced inflammation in the gut. Randomized controlled trials in both adults and children have shown that supplementation with GOS can increase bifidobacterial populations and improve stool consistency, indicating a positive effect on intestinal transit and overall gut function.

Moreover, GOS supplementation has been shown to reduce the incidence and severity of gastrointestinal infections and to alleviate symptoms of irritable bowel syndrome (IBS), such as bloating and abdominal pain. The mechanisms are thought to involve increased production of short-chain fatty acids (SCFAs), which nourish colonocytes and help maintain the integrity of the intestinal lining. While most of the effects are studied in the context of the colon, the modulation of the microbiota begins in the small intestine, contributing to overall digestive health. The scientific consensus, based on several human and animal studies, supports the use of GOS for maintaining and enhancing small intestine function.

More about Galactooligosaccharides
More about Small Intestines

Other ingredients that support Small Intestines

Other body systems supported by Galactooligosaccharides

Products containing Galactooligosaccharides